Japanese startup test kit shows promise in early cancer detection

A urine-based cancer risk screening kit developed by a Japanese startup is showing promise in detecting cancer at the earliest stage using non-invasive means.The test kit from Craif Inc., a spin-off from Nagoya University founded in 2018, can also be used to assess simultaneously whether a person is at risk from any of up to seven types of cancer.The product, which does not require a blood test, was able to detect changes in pre-malignant cells among residents of Hokkaido towns in northern Japan to whom the company distributed 100 sets of the "miSignal" test kit free of charge in the year t…READ FULL ARTICLE